Skip to main content
ホーム / ニュース / Certara Announces Second Year of Fellowship Program in Africa for Applied Pharmacometrics Training

Certara Announces Second Year of Fellowship Program in Africa for Applied Pharmacometrics Training

PRINCETON, N.J.— 2022 年 9 月 25 日 — Certara, Inc, a global leader in biosimulation, today announced that it is expanding its Applied Pharmacometrics Training (APT) fellowship program for doctoral-level scientists from Africa, in partnership with Pharmacometrics Africa, CP+ Associates, and other industry and academic partners.  After its successful first year with sixteen fellows, the program has opened the call for applications for its second cohort.

“We are looking forward to welcoming the second cohort of fellows and are excited to continue advancing our goal of expanding scientific and leadership capabilities in Africa in model-informed drug development,” said Rik de Greef, senior vice president of global quantitative science services at Certara.  “The APT fellows from the first cohort, who are joining the hybrid immersion program, are meeting in Cape Town, South Africa to participate in workshops, where they will delve into the data analysis projects that have been set up by our industry and academic partners.”

The APT in Africa is comprised of a 3-month virtual program that provides fellows with training to conduct regulatory-quality pharmacometrics analyses and reports.  Afterward, fellows can continue for another 3 months in an immersion program where they conduct a data analysis project leading to a publishable unit, under the supervision of subject matter experts.  The second cohort will begin the virtual program of the fellowship in January 2023.

“I am thrilled with the engagement and progress of the first cohort of scientists.  This has exceeded our initial expectations,” said Colin Pillai, Ph.D., CEO of Pharmacometrics Africa and CEO of CP+ Associates.  “I encourage recent doctorate graduates who have completed core training in pharmacometrics and who want to apply quantitative approaches to benefit drug development and clinical practice in Africa to consider applying.”

The fellowship program is accepting applications now.  To learn more or apply, please visit the application site.

Certara(サターラ) について

サターラは、独自のバイオシミュレーションソフトウェア、テクノロジー、コンサルティングサービスを通して、従来の創薬・医薬品開発に変革をもたらすことをミッションとしています。製薬、教育機関、規制当局のお客様 2,000人以上、6262ヵ国にてサターラの技術やサービスが活用されています。

About Pharmacometrics Africa

Pharmacometrics Africa is a not-for-profit company registered in South Africa as a platform for interested groups to establish and run open access quantitative clinical pharmacology educational programs in partnership with local research organizations and academic groups.

About CP+ Associates

CP+ Associates was established in 2017 as a social venture that develops scientific capability in low- and middle-income countries (LMIC), focusing on healthcare via drug discovery, development science and clinical trials.


Jieun Choe
Chief Strategy and Marketing Officer

Pharmacometrics Africa and CP+ Associates Contact:

Rita Michel

Powered by GlobalLink OneLink Software